Reaction crystallization of pharmaceutical molecular complexes

Molecular Pharmaceutics

Volumn 3, Issue 3, 2006, Pages 362-367

  Rodríguez Hornedo, Naír ^a   Nehm, Sarah J ^a   Seefeldt, Kurt F ^a   Pagán Torres, Yomaira ^a   Falkiewicz, Christopher J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cocrystal; Cocrystallization; Raman spectroscopy; Solubility product; Solution mediated transformation

Indexed keywords

CARBAMAZEPINE; NICOTINAMIDE; ORGANIC SOLVENT;

ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; CRYSTALLIZATION; CRYSTALLOGRAPHY; DRUG SOLUBILITY; DRUG STRUCTURE; HIGH THROUGHPUT SCREENING; HYDROGEN BOND; MICROSCOPY; PRIORITY JOURNAL; RAMAN SPECTROMETRY; SOLID; SUSPENSION;

CRYSTALLIZATION; DIETHYLCARBAMAZINE; MACROMOLECULAR SUBSTANCES; MICROSCOPY, POLARIZATION; MODELS, CHEMICAL; NIACINAMIDE; SOLUBILITY; SOLVENTS; SPECTROPHOTOMETRY, INFRARED; SPECTRUM ANALYSIS, RAMAN; X-RAY DIFFRACTION;

EID: 33745788344     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp050099m     Document Type: Article

References (31)

1. Etter, M. C.; Reutzel, S. M. Hydrogen Bond Directed Cocrystallization and Molecular Recognition Properties of Acyclic Imides. J. Am. Chem. Soc. 1991, 113, 2586-2598.
2. Etter, M. C. Hydrogen Bonds as Design Elements in Organic Chemistry. J. Phys. Chem. 1991, 95, 4601-4610.
3. Nangia, A.; Desiraju, G. R. Supramolecular Synthons and Pattern Recognition. Top. Curr. Chem. 1998, 198, 57-95.
4. Desiraju, G. R. Supramolecular Synthons in Crystal Engineering-A New Organic Synthesis. Angew. Chem., Int. Ed. Engl. 1995, 34, 2311-2327.
5. Nehm, S. J.; Rodríguez-Spong, B.; Rodríguez-Hornedo, N. Phase Solubility Diagrams of Cocrystals Are Explained by Solubility Product and Solution Complexation. Cryst. Growth Des. 2006, 6, 592-600.
6. Rodríguez-Spong, B.; Price, C. P.; Jayasankar, A.; Matzger, A. J.; Rodríguez-Hornedo, N. General Principles of Pharmaceutical Solid Polymorphism: A Supramolecular Perspective. Adv. Drug Delivery Rev. 2004, 56, 241-274.
7. Childs, S. L.; Chyall, L. J.; Dunlap, J. T.; Smolenskaya, V. N.; Stahly, B. C.; Stahly, G. P. Crystal Engineering Approach to Forming Cocrystals of Amine Hydrochlorides with Organic Acids. Molecular Complexes of Fluoxetine Hydrochloride with Benzoic, Succinic, and Fumaric Acids. J. Am. Chem. Soc. 2004, 126, 13335-13342.
8. Trask, A. V.; Motherwell, W. D. S.; Jones, W. Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration. Cryst. Growth Des. 2005, 5, 1013-1021.
9. Remenar, J. F.; Morissette, S. L.; Peterson, M. L.; Moulton, B.; MacPhee, J. M.; Guzman, H. R.; Almarsson, O. Crystal Engineering of Novel Cocrystals of a Triazole Drug with 1,4-Dicarboxylic Acids. J. Am. Chem. Soc. 2003, 125, 8456-8457.
10. Zocharski, P.; Nehm, S.; Rodríguez-Spong, B.; Rodríguez- Hornedo, N. Can Solubility Products Explain Cocrystal Solubility and Predict Crystallization Conditions? AAPS J. 2004, 6, Abstract R6192.
11. Rodríguez-Spong, B.; Zocharski, P.; Billups, J.; McMahon, J.; Zaworotko, M. J.; Rodríguez-Hornedo, N. Enhancing the Pharmaceutical Behavior of Carbamazepine Through the Formation of Cocrystals. AAPS J. 2003, 5, Abstract M1298.
12. Rodríguez-Spong, B. Enhancing the Pharmaceutical Behavior of Poorly Soluble Drugs Through the Formation of Cocrystals and Mesophases. Ph.D. Thesis, University of Michigan, 2005.
13. Pedireddi, V. R.; Jones, W.; Chorlton, A. P.; Docherty, R. Creation of Crystalline Supramolecular Arrays: A Comparison of Cocrystal Formation from Solution and By Solid-state Grinding. Chem. Commun. 1996, 987-988.
14. Etter, M. C. Encoding and Decoding Hydrogen-Bond Patterns of Organic Compounds. Acc. Chem. Res. 1990, 23, 120-126.
15. Desiraju, G. R. Hydrogen Bridges in Crystal Engineering: Interactions without Borders. Acc. Chem. Res. 2002, 35, 565-573.
16. Desiraju, G. R. Designer Crystals: Intermolecular Interactions, Network Structures and Supramolecular Synthons. Chem. Commun. 1997, 1475-1482.
17. Leiserowitz, L.; Schmidt, G. M. J. Molecular Packing Modes. Part III. Primary Amides. J. Chem. Soc. A 1969, 2372-2382.
18. Fleischman, S. G.; Kuduva, S. S.; McMahon, J. A.; Moulton, B.; Walsh, R. D. B.; Rodríguez-Hornedo, N.; Zaworotko, M. J. Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving Carbamazepine. Cryst. Growth Des. 2003, 3, 909-919.
19. Walsh, R. D. B.; Bradner, M. W.; Fleischman, S.; Morales, L. A.; Moulton, B.; Rodríguez-Hornedo, N.; Zaworotko, M. J. Crystal Engineering of the Composition of Pharmaceutical Phases. Chem. Commun. 2003, 186-187.
20. Vishweshwar, P.; McMahon, J.; Peterson, M. L.; Hickey, M. B.; Shattock, T. R.: Zaworotko, M. J. Crystal Engineering of Pharmaceutical Co-crystals from Polymorphic Active Pharmaceutical Ingredients. Chem. Commun. 2005, 4601-4603.
21. Madarasz, J.; Bombicz, P.; Jarmi, K.; Ban, M.; Pokol, G.; Gal, S. Thermal, FTIR and XRD Study on Some 1:1 Molecular Compounds of Theophylline. J. Therm. Anal. Calorim. 2002, 69, 281-290.
22. Caira, M. R. Molecular Complexes of Sulfonamides. Part 1. 1:1 Complexes Between Sulfadimidine [4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide] and 2- and 4-aminobenzoic acids. J. Crystallogr. Spectrosc. Res. 1991, 21, 641-648.
23. Caira, M. R. Molecular Complexes of Sulfonamides. 2. 1:1 Complexes Between Drug Molecules: Sulfadimidine-acetylsalicylic acid and Sulfadimidine-4-aminosalicylic acid. J. Crystallogr. Spectrosc. Res. 1992, 22, 193-200.
24. Ghosh, M,; Basak, A. K.; Mazumdar, S. K. Structure and Conformation of the 1:1 Molecular Complex of Sulfaproxyline-Caffeine. Acta Crystallogr. 1991, C47, 577-580.
25. Bettinetti, G.; Caira, M. R.; Callegari, A.; Merli, M.; Sorrenti, M.; Tadini, C. Structure and Solid-State Chemistry of Anhydrous and Hydrated Crystal Forms of the Trimethoprim-Sulfamethoxypyridazine 1:1 Molecular Complex. J. Pharm. Sci. 2000, 89, 478-489.
26. Morissette, S. L.; Almarsson, O.; Peterson, M. L.; Remenar, J. F.; Read, M. J.; Lemmo, A. V.; Ellis, S.; Cima, M. J.; Gardner, C. R. High-throughput Crystallization: Polymorphs, Salts, Cocrystals and Solvates of Pharmaceutical Solids. Adv. Drug Delivery Rev. 2004, 56, 275-300.
27. Allen, F. H. The Cambridge Structural Database: A Quarter of a Million Crystal Structures and Rising. Acta Crystallogr. 2002, B58, 380-388.
28. Rodríguez-Clemente, R. Complexing and Growth Units in Crystal Growth from Solutions of Electrolytes. J. Cryst. Growth 1989, 98, 617-629.
29. Nielsen, A. E.; Toft, J. M. Electrolyte Crystal Growth Kinetics. J. Cryst. Growth 1984, 67, 278-288.
30. Khankari, R. K.; Grant, D. J. W. Pharmaceutical Hydrates. Thermochim. Acta 1995, 248, 61-79.
31. Tomazic, B.; Nancollas, G. H. The Kinetics of Dissolution of Calcium Oxalate Hydrates. J. Cryst. Growth 1979, 46, 355-361.